Thrivent Financial for Lutherans’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $431M | Buy |
468,846
+3,836
| +0.8% | +$3.89M | 0.82% | 13 |
|
|
2025
Q4 | $500M | Buy |
465,010
+9,296
| +2% | +$8.89M | 0.89% | 13 |
|
|
2025
Q3 | $348M | Buy |
455,714
+5,787
| +1% | +$4.31M | 0.68% | 15 |
|
|
2025
Q2 | $351M | Buy |
449,927
+52,783
| +13% | +$41M | 0.77% | 12 |
|
|
2025
Q1 | $328M | Sell |
397,144
-71,592
| -15% | -$59.6M | 0.72% | 13 |
|
|
2024
Q4 | $363M | Buy |
468,736
+40,776
| +10% | +$33.8M | 0.7% | 10 |
|
|
2024
Q3 | $379M | Buy |
427,960
+62,378
| +17% | +$56.1M | 0.72% | 8 |
|
|
2024
Q2 | $331M | Buy |
365,582
+133,475
| +58% | +$107M | 0.67% | 12 |
|
|
2024
Q1 | $181M | Buy |
232,107
+124,984
| +117% | +$88.9M | 0.36% | 50 |
|
|
2023
Q4 | $62.4M | Sell |
107,123
-6,956
| -6% | -$4.06M | 0.14% | 216 |
|
|
2023
Q3 | $61.3M | Sell |
114,079
-5,878
| -5% | -$3.03M | 0.15% | 195 |
|
|
2023
Q2 | $56.2M | Buy |
119,957
+40,963
| +52% | +$17.2M | 0.13% | 216 |
|
|
2023
Q1 | $27.1M | Buy |
78,994
+775
| +1% | +$261K | 0.07% | 350 |
|
|
2022
Q4 | $28.6M | Sell |
78,219
-9,048
| -10% | -$3.21M | 0.07% | 330 |
|
|
2022
Q3 | $28.3M | Sell |
87,267
-3,504
| -4% | -$1.11M | 0.08% | 307 |
|
|
2022
Q2 | $29.4M | Sell |
90,771
-58,515
| -39% | -$17.6M | 0.08% | 301 |
|
|
2022
Q1 | $42.1M | Sell |
149,286
-6,637
| -4% | -$1.71M | 0.08% | 281 |
|
|
2021
Q4 | $39.2M | Sell |
155,923
-41,257
| -21% | -$10.5M | 0.08% | 299 |
|
|
2021
Q3 | $45.5M | Sell |
197,180
-119
| -0.1% | -$29.4K | 0.09% | 259 |
|
|
2021
Q2 | $45.3M | Sell |
197,299
-4,587
| -2% | -$921K | 0.09% | 265 |
|
|
2021
Q1 | $37.7M | Sell |
201,886
-52,716
| -21% | -$10.3M | 0.08% | 288 |
|
|
2020
Q4 | $43M | Sell |
254,602
-60,326
| -19% | -$9.01M | 0.1% | 264 |
|
|
2020
Q3 | $46.6M | Buy |
314,928
+87,658
| +39% | +$13.6M | 0.12% | 198 |
|
|
2020
Q2 | $35.4M | Buy |
227,270
+87,077
| +62% | +$13.4M | 0.11% | 233 |
|
|
2020
Q1 | $19.4M | Buy |
140,193
+54,401
| +63% | +$7.47M | 0.07% | 322 |
|
|
2019
Q4 | $11.3M | Sell |
85,792
-1,675
| -2% | -$194K | 0.03% | 537 |
|
|
2019
Q3 | $9.78M | Buy |
87,467
+443
| +0.5% | +$49.3K | 0.03% | 509 |
|
|
2019
Q2 | $9.64M | Sell |
87,024
-61,755
| -42% | -$7.27M | 0.03% | 528 |
|
|
2019
Q1 | $19.3M | Sell |
148,779
-194,494
| -57% | -$23.7M | 0.06% | 330 |
|
|
2018
Q4 | $39.5M | Buy |
343,273
+7,929
| +2% | +$886K | 0.14% | 176 |
|
|
2018
Q3 | $36M | Sell |
335,344
-10,058
| -3% | -$1.01M | 0.11% | 198 |
|
|
2018
Q2 | $29.5M | Sell |
345,402
-1,192
| -0.3% | -$97.9K | 0.1% | 214 |
|
|
2018
Q1 | $26.8M | Buy |
346,594
+206,748
| +148% | +$16.6M | 0.09% | 210 |
|
|
2017
Q4 | $11.8M | Buy |
139,846
+47,461
| +51% | +$4.04M | 0.04% | 422 |
|
|
2017
Q3 | $7.9M | Buy |
92,385
+53,315
| +136% | +$4.37M | 0.03% | 497 |
|
|
2017
Q2 | $3.21M | Buy |
39,070
+1,654
| +4% | +$135K | 0.01% | 698 |
|
|
2017
Q1 | $3.14M | Buy |
37,416
+2,850
| +8% | +$228K | 0.01% | 706 |
|
|
2016
Q4 | $2.54M | Buy |
34,566
+1,790
| +5% | +$133K | 0.01% | 782 |
|
|
2016
Q3 | $2.63M | Buy |
32,776
+1,820
| +6% | +$146K | 0.01% | 783 |
|
|
2016
Q2 | $2.44M | Buy |
30,956
+1,556
| +5% | +$117K | 0.01% | 805 |
|
|
2016
Q1 | $2.12M | Buy |
29,400
+1,470
| +5% | +$111K | 0.01% | 848 |
|
|
2015
Q4 | $2.35M | Buy |
27,930
+1,280
| +5% | +$106K | 0.01% | 798 |
|
|
2015
Q3 | $2.23M | Buy |
26,650
+550
| +2% | +$46.4K | 0.01% | 765 |
|
|
2015
Q2 | $2.18M | Sell |
26,100
-19,881
| -43% | -$1.51M | 0.01% | 644 |
|
|
2015
Q1 | $3.34M | Buy |
45,981
+800
| +2% | +$57K | 0.02% | 574 |
|
|
2014
Q4 | $3.12M | Sell |
45,181
-800
| -2% | -$54K | 0.02% | 587 |
|
|
2014
Q3 | $2.98M | Buy |
45,981
+2,300
| +5% | +$146K | 0.02% | 606 |
|
|
2014
Q2 | $2.72M | Buy |
43,681
+450
| +1% | +$26.8K | 0.02% | 638 |
|
|
2014
Q1 | $2.54M | Buy |
43,231
+1,950
| +5% | +$109K | 0.02% | 543 |
|
|
2013
Q4 | $2.11M | Sell |
41,281
-1,816,270
| -98% | -$91M | 0.01% | 593 |
|
|
2013
Q3 | $93.5M | Buy |
1,857,551
+11,681
| +0.6% | +$612K | 0.59% | 45 |
|
|
2013
Q2 | $90.7K | Buy |
+1,845,870
| New | +$100M | 0.59% | 41 |
|
Other funds holding LLY
VCM
VPM
Thrivent Financial for Lutherans's LLY Position: Q1 2026 in Review
Thrivent Financial for Lutherans increased its Eli Lilly (LLY) stake by 0.82% in Q1 2026, buying an estimated $3.89M and bringing the position to 468,846 shares worth $431M. The position accounts for 0.82% of the portfolio, ranked #13.
Thrivent Financial for Lutherans first reported a position in LLY in Q2 2013 and has held it in 52 quarters since. The position peaked at $500M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Thrivent Financial for Lutherans held 468,846 shares of Eli Lilly worth $431M as of Q1 2026.
- Thrivent Financial for Lutherans bought 3,836 Eli Lilly shares in Q1 2026, an estimated $3.89M.
- Eli Lilly made up 0.82% of Thrivent Financial for Lutherans's portfolio in Q1 2026, its #13 holding.
- Thrivent Financial for Lutherans first reported a position in Eli Lilly in Q2 2013 and has held it in 52 quarters since.
- Thrivent Financial for Lutherans's Eli Lilly position peaked at $500M in Q4 2025.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Thrivent Financial for Lutherans's 13F filing for Q1 2026, filed 1 May 2026.